THE CHAIRMAN IN HONG KONG IS THE ONLY CHINESE CUISINE RESTAURANT TO EARN A SPOT IN THE WORLD’S 50 BEST RESTAURANTS AWARDS 2021

The Chairman took the No.10 spot in the World’s 50 Best Restaurants Awards 2021 (Photo: Business Wire)

HONG KONG, Oct 7 (Bernama-BUSINESS WIRE)–The Chairman, a Cantonese restaurant in Central, renowned for its authentic, ingredients-driven cuisine, took the No.10 spot in the World’s 50 Best Restaurants Awards 2021. A new entrant into this year’s top ten, The Chairman was also the recipient of the Highest Climber Award, having risen an impressive 31 places from its previous ranking.

This press release features multimedia. View the full release here: 
https://www.businesswire.com/news/home/20211006005557/en/

Held on 5th October in Antwerp, Flanders, the World’s 50 Best Restaurants Awards 2021 saw restaurants from 26 countries across five continents place on the list. The Chairman was the only Chinese cuisine restaurant on the list. The news come after The Chairman won two coveted titles – The Best Restaurant in Asia and The Best Restaurant in China – in March 2021 in the Asia’s 50 Best Restaurants Awards 2021.

The World’s 50 Best Restaurants also revealed its list of restaurants ranked from 51st to 100th. Hong Kong is represented by Vea (No.71), Belon (No.88) and Amber (No.100).

The World’s 50 Best Restaurants Academy, an influential group of more than 1,000 leaders, made up of food writers and critics, chefs, restaurateurs and international culinary experts, votes and creates the annual list of restaurants.

For the full list, please visit https://www.theworlds50best.com/list/1-50.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20211006005557/en/

Contact

For media enquiries, please contact:
Ms Vivian Li
Tel: 2807 6206
Email: vivian.li@hktb.com

During non-office hours, please call 8200 7860.

Source : Hong Kong Tourism Board

–BERNAMA

MEDICAL DEVICE AUTHORITY APPROVES TRIPLEX INTERNATIONAL BIOSCIENCES’ SARS-COV-2 ANTIGEN RAPID TEST KIT (SALIVA) FOR SELF-TEST IN MALAYSIA

MDA approved- TIB Covid-19 Saliva Self Test. Highest Sensitivity, accuracy and specificity, evaluated by IMR, Malaysia

KUALA LUMPUR, Malaysia, Oct 5 (Bernama) — Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing. 

Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%. The test kit works by detecting the presence of the coronavirus nucleocapsid protein in saliva samples. Infants under the age of two are not recommended to use this test kit. 

“With the relentless spread of COVID-19, new variants and the huge strain on public healthcare systems, this easy-to-use saliva self-test kit meets the demand for a quick, affordable and accurate way to detect the virus, thereby aiding virus containment efforts,” said Sidney Soares, Chief Executive Officer, Universal Therapeutics.  

The kit will be made available through Universal Therapeutics’ network of hospitals, medical facilities, medical institutions and pharmacies.

For more information, please visit https://www.universal-therapeutics.com

For MDA’s list of approved COVID-19 test kits, visit
https://portal.mda.gov.my/announcement/631-self-test-covid-19-test-kit-for-conditional-approval-approved.html 

About Universal Therapeutics:
Universal Therapeutics is a multinational pharmaceutical and biotech company based in Kuala Lumpur, Malaysia. The company’s businesses include manufacturing, distribution and white label production of pharmaceutical products, medical supplies, and PPEs in Asia and throughout the world.

Universal Therapeutics distributes nitrile gloves; three-ply face masks; KN95 and N95 masks; Covid-19 Rapid Antigen tests to wholesalers, medical institutions, and government organisations. All our products comply with World Health Organization (WHO) guidelines and are accredited and approved by various health ministries as safe for human use. 

Source:Universal Therapeutics

FOR MORE INFORMATION, PLEASE CONTACT:
Name: Samuel CHAI
Chief Commercial Officer
Tel: +60 3 9213 0318
Email: GroupPR@Universal-Therapeutics.com
Website: www.Universal-Therapeutics.com 

–BERNAMA

USHERING IN A NEW ERA OF MEDICAL EDUCATION AT NTHU

College of Life Science dean Kao Ruey-Ho (left) and Department of Medical Science chair Chen Linyi (right) prepare for the post-baccalaureate program in medicine. (Photo: National Tsing Hua University)

College of Life Science dean Kao Ruey-Ho (left) and Department of Medical Science chair Chen Linyi (right) prepare for the post-baccalaureate program in medicine. (Photo: National Tsing Hua University)

HSINCHU, Taiwan, Oct 4 (Bernama-BUSINESS WIRE) — National Tsing Hua University’s plan to establish a post-baccalaureate program in medicine has been approved at a recent cross-ministerial meeting held at the Ministry of Education. The school’s recruitment and admission application process will begin by the end of 2021, and the first class of government-sponsored students will be enrolled in September 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211001005043/en/ NTHU President Hocheng Hong said that NTHU already has a strong foundation in cross-disciplinary research in medical science, including big data analysis, application of artificial intelligence (AI), bioengineering, material science, and nuclear medicine, by which the school is well-positioned to train physicians specializing in more than one expertise. As such, this new program represents a quantum jump in medical education in Taiwan.

President Hocheng said that NTHU already has sufficient number of faculty members, funding, and infrastructure for the new program. In addition to the existing 180 faculty members teaching related courses, the program has recently recruited an additional 71 full-time faculty members, and 87 physician scientists from leading medical centers throughout Taiwan as adjunct faculty members. Moreover, the provisional office of this program has raised NT$2 billion for medical education. An ongoing plan for establishing a state-of-the-art teaching hospital and medical complex in the Taoyuan Aerotropolis next to the Taoyuan International Airport is currently being reviewed by the Ministry of Health and Welfare.

The post-baccalaureate program in medicine is a four-year program, open for graduates from all disciplines. The government-sponsored students will be required to serve in a public healthcare facility for six years. They will have an opportunity to undertake an additional two years of advanced training in a medical center.

NTHU will draw on its extensive experience in student recruitment to admit only those applicants who meet the stringent admission qualifications, the innovative student selection process could open a new path for medical education in Taiwan.

The post-baccalaureate program in medicine will be part of the future College of Life Sciences and Medicine (currently the College of Life Science). Dean of the College of Life Science, Kao Ruey-Ho, former Superintendent of Tzu Chi Medical Center, said that applicants who apply directly to NTHU will be evaluated based on test scores, transcripts, and interviews, to select students who have demonstrated academic excellence, as well as a passion for medicine and public welfare.

Government-sponsored students in the program will take several courses designed to prepare them for practicing in a rural area, such as Community Medicine Practicum, and make good use of AI diagnosis and telemedicine technology; they will also attend seminars on altruism and dedication to public health, which will be taught by laureates of the Medical Contribution Award.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20211001005043/en/

Contact

Holly Hsueh
NTHU
(886)3-5162006
hoyu@mx.nthu.edu.tw

Source : National Tsing Hua University

GLOBAL SMART GRID DEPLOYMENT WILL SAVE 1,060 TERAWATT-HOURS IN ENERGY BY 2026 – JUNIPER RESEARCH

KUALA LUMPUR, Oct 4 (Bernama) — A new Juniper Research study has found global smart grid deployments will lead to annual energy savings of 1,060 terawatt-hours by 2026, from 316 terawatt-hours this year.

The research identified increased sustainability and energy security as critical to the appeal of smart grids, with analytics and demand-responsive networks able to have a dramatic impact in a renewables-heavy future, according to a statement.

The report predicts vendors who can best combine analytics that deliver operational insights to energy companies, with low-cost sensors and connectivity, will achieve greatest success.

The new research, Smart Grid: Industry Trends, Competitor Leaderboard and Market Forecasts 2021-2026, found that smart grid software, which analyses energy usage in real-time to enable responsive features for utility companies, will be critical to delivering energy and cost savings.

Research co-author Damla Sat explained: “To meet ambitious climate targets and lower spiralling operating costs for utility companies, the grid must evolve rapidly into a smart grid.”

“Leveraging connectivity and deploying analytics at scale will be vital in achieving the truly demand-responsive grid that is needed today.”

The research found that smart metering roll-outs are growing, with global smart meters in service set to reach over two billion in 2026, from 1.1 billion in 2021.

While this represents growth of just under 95 per cent, adoption is very uneven worldwide, with markets including Latin America and Africa & Middle East lagging significantly behind the leaders in Western Europe and the Far East & China.

The research recommends that vendors lobby governments urgently to support smart metering roll-outs, or they will rapidly fall further behind.

Juniper Research provides research and analytical services to the global hi-tech communications sector; providing consultancy, analyst reports and industry commentary.

— BERNAMA

MANULIFE MALAYSIA PROVIDES COVID-19 VACCINATION SUPPORT TO EMPLOYEES AND ANNOUNCES 5 EXTRA PERSONAL DAYS IN 2022

KUALA LUMPUR, Oct 1 (Bernama) — In light of the evolving COVID-19 situation, Manulife Malaysia is helping employees and customers to stay safe and resilient with a number of initiatives, including facilitating vaccination and providing extra days off for employees, and offering financial assistance to customers.

Through Malaysia’s National COVID-19 Immunisation Programme, Manulife Malaysia is supporting employees and their family members who have not received their vaccination to get vaccinated more conveniently at prearranged clinics and health centres across various states in the country. This arrangement, which began in 22 July 2021, has since facilitated the vaccination of Manulife Malaysia’s branch employees.

Looking ahead to 2022, Manulife Malaysia is once again giving all employees five additional personal days to use next year in appreciation of all the hard work they have done to help make every day better for customers across Malaysia. Manulife Malaysia is also announcing “Fuel Up Fridays”, a Manulife global initiative to support employee well-being. The initiative sets aside the second Friday of each month through the end of the year to “fuelling up” through a morning of collective learning, followed by an afternoon off to recharge physically and mentally.

With customer centricity a key focus, Manulife Insurance Berhad’s (MIB) customers have also been supported with a RM1 million Special Financial Assistance Programme (SFAP) since 26 February 2020. The programme gives policyholders a daily income of RM200 upon diagnosis of COVID-19 and compassionate benefit of up to RM15,000. Since 1 June 2021, MIB has allocated an additional RM500,000 under SFAP 2.0 to continue supporting policyholders who are affected by COVID-19. Both programmes have since been fully redeemed, benefitting over 600 customers.

“Our team in Malaysia has demonstrated tremendous resilience as we continue to navigate the pandemic by supporting our employees, our customers and our communities, said Vibha Coburn, Group Chief Executive Officer of Manulife Malaysia. “These initiatives are driven by our desire to provide meaningful support that helps our employees and customers in very tangible ways, and that’s why we’ll continue to take a holistic approach to supporting their physical and mental well-being.”

About Manulife Malaysia https://www.manulife.com.my/en/individual/about-us/about-manulife-malaysia.html
Source: Manulife Insurance Berhad

FOR MORE INFORMATION, PLEASE CONTACT:

Name: Asha Devi
Senior Manager, Brand & Communications
Manulife Insurance Berhad
Tel: (603) 2719 9294
Email: asha_devi@manulife.com 

–BERNAMA